| View |
|
DR-XY35610
|
Metoprolol
|
Hypetor
|
100 mg
|
Film-Coated Tablet
|
Beta Adrenoceptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 December 2023
|
18 March 2029
|
| View |
|
DR-XY35636
|
Cefaclor (as monohydrate)
|
Ephron
|
250 mg/5 mL
|
Granules for Suspension (Orange Flavor)
|
Antibacterial (Second Generation Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
01 March 2024
|
24 March 2029
|
| View |
|
DR-XY35642
|
Co-amoxiclav
|
Myclav-375
|
250 mg / 125 mg
|
Film-Coated Tablet
|
Antibacterial
|
Unichem Laboratories Ltd.
|
India
|
Renewal
|
07 July 2024
|
13 August 2029
|
| View |
|
DR-XY35650
|
ALLOPURINOL
|
PRINOL
|
100 mg
|
Capsule
|
ANTI-GOUT
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
11 March 2024
|
01 April 2029
|
| View |
|
DR-XY35661
|
Cefuroxime (as Sodium)
|
Zefuxim
|
1.5g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
01 March 2024
|
02 April 2029
|
| View |
|
DR-XY35664
|
Cerebrolysin
|
None
|
215.2mg/mL
|
Concentrate Solution for IV Infusion
|
-
|
EVER Neuro Pharma GmbH
|
Austria
|
-
|
27 November 2020
|
20 January 2026
|
| View |
|
DR-XY35672
|
Cefoxitin (as Sodium)
|
Zepotin
|
1g
|
Powder For Injection (Im/Iv)
|
Antibacterial (Secondary Generation Cephalosporin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
12 February 2024
|
07 April 2029
|
| View |
|
DR-XY35687
|
Co-amoxiclav
|
Clavimox
|
1.2 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Renewal
|
10 May 2024
|
16 April 2029
|
| View |
|
DR-XY35701
|
L-Carnitine
|
Cartine
|
200mg/mL
|
Solution For Injection (I.V.)
|
Metabolic Energizer
|
Huons Co., Ltd.
|
Korea
|
Renewal
|
23 May 2024
|
21 April 2029
|
| View |
|
DR-XY35703
|
CEFACLOR (AS MONOHYDRATE)
|
CLORCEF
|
50mg/mL
|
Granules For Suspension (Oral Drops)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
19 February 2024
|
21 April 2029
|
| View |
|
DR-XY35704
|
CIPROFLOXACIN
|
Unbranded
|
3mg/mL(0.3% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Fluroquinolone)
|
E.L. Laboratories, Inc
|
Philippines
|
Renewal
|
10 March 2024
|
21 April 2029
|
| View |
DR-XY35708_PI_01.pdf
|
DR-XY35708
|
LOSARTAN POTASSIUM + HYDROCHLORIDE
|
NEOSARTAN PLUS
|
50 mg/12.50 mg
|
Film-Coated Tablet
|
ANGIOTENSIN II RECEPTOR BLOCKER/DIURETIC
|
Hizon Laboratories, Inc
|
Philippines
|
Renewal
|
19 December 2023
|
22 April 2029
|
| View |
|
DR-XY35723
|
Ascorbic Acid
|
Calcimed
|
500mg (Equi. To 605.20mg Calcium Ascorbate)
|
Capsule
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
02 January 2024
|
22 April 2029
|
| View |
|
DR-XY35736
|
Clarithromycin
|
Klaz
|
250 mg/5 mL
|
Granules For Oral Injection
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
27 April 2022
|
27 April 2027
|
| View |
|
DR-XY35742
|
Ceftriaxone (as Sodium)
|
Ceftrox
|
1g
|
Powder for Injection
|
Antibacterial (Third Generation Cephalosporin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
23 February 2024
|
24 April 2029
|
| View |
|
DR-XY35745
|
Atorvastatin (as Calcium)
|
Atopitar
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Geofman Pharmaceuticals
|
Pakistan
|
Renewal
|
08 May 2024
|
27 April 2029
|
| View |
|
DR-XY35746
|
Diclofenac (as Diethylamine)
|
Clogel
|
10 mg/G (1% W/W)
|
Topical Gel
|
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
07 April 2024
|
27 April 2029
|
| View |
|
DR-XY35758
|
Ceftriaxone (as Sodium)
|
Ceftrox
|
250mg
|
Powder For Injection (I.M./I.V)
|
Antibacterial (Cephalosporins)
|
Singapore Pharmawealth Lifesciences, Inc.,
|
Philippines
|
Renewal
|
20 February 2024
|
29 April 2029
|
| View |
|
DR-XY35760
|
Ceftriaxone (as Sodium)
|
Ceftrox
|
500mg
|
Powder for Injection
|
Antibacterial (Third Generation Cephalosporin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
19 February 2024
|
29 April 2029
|
| View |
|
DR-XY35761
|
Lipids with Omega-3
|
Lipidem
|
Formulation:
Each 1,000 mL emulsion contains:
Medium-chain triglycerides 100 g
Soya-bean oil 80 g
Omega-3 acid triglycerides 20 g
|
Emulsion for Intravenous Infusion
|
Parenteral Nutrition
|
B. Braun Melsungen AG
|
Germany
|
Initial (Variation)
|
30 July 2024
|
30 July 2029
|